152 related articles for article (PubMed ID: 15601956)
1. The obesity pandemic: where have we been and where are we going?
Roth J; Qiang X; Marbán SL; Redelt H; Lowell BC
Obes Res; 2004 Nov; 12 Suppl 2():88S-101S. PubMed ID: 15601956
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
3. [Adipocytokins, obesity and development of type 2 diabetes].
Lacquemant C; Vasseur F; Leprêtre F; Froguel P
Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
[TBL] [Abstract][Full Text] [Related]
4. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection.
Cohen PG
Med Hypotheses; 2001 Jun; 56(6):702-8. PubMed ID: 11399122
[TBL] [Abstract][Full Text] [Related]
5. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.
Alam I; Lewis K; Stephens JW; Baxter JN
Obes Rev; 2007 Mar; 8(2):119-27. PubMed ID: 17300278
[TBL] [Abstract][Full Text] [Related]
6. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance.
Zhao B; Wall RJ; Yang J
Biochem Biophys Res Commun; 2005 Nov; 337(1):248-55. PubMed ID: 16182246
[TBL] [Abstract][Full Text] [Related]
7. Early obesity and age-related mimicry of metabolic syndrome in female mice with sex hormonal imbalances.
Sairam MR; Wang M; Danilovich N; Javeshghani D; Maysinger D
Obesity (Silver Spring); 2006 Jul; 14(7):1142-54. PubMed ID: 16899795
[TBL] [Abstract][Full Text] [Related]
8. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development.
Sébert SP; Lecannu G; Kozlowski F; Siliart B; Bard JM; Krempf M; Champ MM
Int J Obes (Lond); 2005 Mar; 29(3):324-33. PubMed ID: 15672115
[TBL] [Abstract][Full Text] [Related]
9. [The adipose tissue as an endocrine organ].
Szendrödi J; Roden M
Acta Med Austriaca; 2004; 31(4):98-111. PubMed ID: 15732243
[TBL] [Abstract][Full Text] [Related]
10. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
11. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
Fain JN
Vitam Horm; 2006; 74():443-77. PubMed ID: 17027526
[TBL] [Abstract][Full Text] [Related]
12. Fatty liver: a novel component of the metabolic syndrome.
Kotronen A; Yki-Järvinen H
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317
[TBL] [Abstract][Full Text] [Related]
13. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
[TBL] [Abstract][Full Text] [Related]
14. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
15. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.
Lu JY; Huang KC; Chang LC; Huang YS; Chi YC; Su TC; Chen CL; Yang WS
J Biomed Sci; 2008 Sep; 15(5):565-76. PubMed ID: 18535923
[TBL] [Abstract][Full Text] [Related]
17. A role for suppressed skeletal muscle thermogenesis in pathways from weight fluctuations to the insulin resistance syndrome.
Dulloo AG
Acta Physiol Scand; 2005 Aug; 184(4):295-307. PubMed ID: 16026421
[TBL] [Abstract][Full Text] [Related]
18. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
20. Health consequences of obesity in the elderly: a review of four unresolved questions.
Zamboni M; Mazzali G; Zoico E; Harris TB; Meigs JB; Di Francesco V; Fantin F; Bissoli L; Bosello O
Int J Obes (Lond); 2005 Sep; 29(9):1011-29. PubMed ID: 15925957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
